The Role of Adjuvant Radiation in Uterine Sarcomas

International Journal of Radiation Oncology Biology Physics

Volumn 76, Issue 3, 2010, Pages 728-734

  Sampath, Sagus ^a   Schultheiss, Timothy E ^b   Ryu, Janice K ^a   Wong, Jeffrey Y C ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

Author keywords

Adjuvant radiotherapy; Carcinosarcoma; Local failure; Uterine sarcoma

Indexed keywords

ADJUVANT RADIATION; ADJUVANT RADIOTHERAPY; BRACHYTHERAPY; CANCER PATIENTS; CARCINOSARCOMA; CLINICAL PRACTICES; EXTERNAL BEAM RADIATION; HAZARD RATIO; KAPLAN-MEIER METHOD; LEIOMYOSARCOMA; LOCAL FAILURE; LYMPH NODE; MEDICAL SYSTEMS; MULTIVARIATE ANALYSIS; OVERALL SURVIVAL; PROGNOSTIC FACTORS; PROPORTIONAL HAZARDS MODEL; RANK TEST; REGIONAL FAILURES; RETROSPECTIVE ANALYSIS; SURGICAL TREATMENT; UP TIME;

ARGON; BIOLOGICAL RADIATION EFFECTS; BODY FLUIDS; DATABASE SYSTEMS; DECISION MAKING; HISTOLOGY; MULTIVARIANT ANALYSIS; ONCOLOGY; RADIOTHERAPY; SURGERY;

TUMORS;

ADULT; AGED; ARTICLE; BRACHYTHERAPY; CANCER ADJUVANT THERAPY; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER REGISTRY; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CARCINOSARCOMA; CONTROLLED STUDY; DATA BASE; ENDOMETRIUM SARCOMA; ETHNICITY; EXTERNAL BEAM RADIOTHERAPY; FEMALE; FOLLOW UP; HAZARD RATIO; HISTOLOGY; HUMAN; KAPLAN MEIER METHOD; LEIOMYOSARCOMA; LOG RANK TEST; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MULTIVARIATE ANALYSIS; ONCOLOGY; OVERALL SURVIVAL; PREDICTION; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; RETROSPECTIVE STUDY; TREATMENT OUTCOME; UTERUS SARCOMA;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; DATABASES, FACTUAL; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; MIDDLE AGED; MULTIVARIATE ANALYSIS; PROGNOSIS; RADIOTHERAPY, ADJUVANT; RETROSPECTIVE STUDIES; SARCOMA; UTERINE NEOPLASMS; YOUNG ADULT;

EID: 76049112604     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2009.02.077     Document Type: Article

References (29)

1. Olah K.S., Gee H., Blunt S., et al. Retrospective analysis of 318 cases of uterine sarcoma. Eur J Cancer 27 (1991) 1095-1099
2. Major F.J., Blessing J.A., Silverberg S.G., et al. Prognostic factors in early-stage uterine sarcoma. A Gynecologic Oncology Group study. Cancer 71 (1993) 1702-1709
3. Callister M., Ramondetta L.M., Jhingran A., et al. Malignant mixed Mullerian tumors of the uterus: Analysis of patterns of failure, prognostic factors, and treatment outcome. Int J Radiat Oncol Biol Phys 58 (2004) 786-796
4. Sorbe B., and Johansson B. Prophylactic pelvic irradiation as part of primary therapy in uterine sarcomas. Int J Oncol 32 (2008) 1111-1117
5. Ferrer F., Sabater S., Farrus B., et al. Impact of radiotherapy on local control and survival in uterine sarcomas: A retrospective study from the Grup Oncologic Catala-Occita. Int J Radiat Oncol Biol Phys 44 (1999) 47-52
6. Livi L., Paiar F., Shah N., et al. Uterine sarcoma: Twenty-seven years of experience. Int J Radiat Oncol Biol Phys 57 (2003) 1366-1373
7. Reed N.S., Mangioni C., Malmstrom H., et al. Phase III randomised study to evaluate the role of adjuvant pelvic radiotherapy in the treatment of uterine sarcomas stages I and II: An European Organisation for Research and Treatment of Cancer Gynaecological Cancer Group Study (protocol 55874). Eur J Cancer 44 (2008) 808-818
8. Pezner R.D., Schultheiss T.E., and Paz I.B. Malignant phyllodes tumor of the breast: Local control rates with surgery alone. Int J Radiat Oncol Biol Phys 71 (2008) 710-713
9. Fritz A.G. International classification of diseases for oncology: ICD-O. 3rd ed. (2000), World Health Organization, Geneva
10. Kaplan E., and Meier P. Nonparametric estimation for incomplete observations. J Am Stat Assoc 53 (1958) 457-481
11. Cox D. Regression model and life tables. J R Stat Soc 34 (1972) 187-220
12. Moskovic E., MacSweeney E., Law M., et al. Survival, patterns of spread and prognostic factors in uterine sarcoma: A study of 76 patients. Br J Radiol 66 (1993) 1009-1015
13. Gerszten K., Faul C., Kounelis S., et al. The impact of adjuvant radiotherapy on carcinosarcoma of the uterus. Gynecol Oncol 68 (1998) 8-13
14. Vongtama V., Karlen J.R., Piver S.M., et al. Treatment, results and prognostic factors in stage I and II sarcomas of the corpus uteri. AJR Am J Roentgenol 126 (1976) 139-147
15. Nordal R.R., and Thoresen S.O. Uterine sarcomas in Norway 1956-1992: Incidence, survival and mortality. Eur J Cancer 33 (1997) 907-911
16. Wolfson A.H., Wolfson D.J., Sittler S.Y., et al. A multivariate analysis of clinicopathologic factors for predicting outcome in uterine sarcomas. Gynecol Oncol 52 (1994) 56-62
17. Gadducci A., Sartori E., Landoni F., et al. The prognostic relevance of histological type in uterine sarcomas: A Cooperation Task Force (CTF) multivariate analysis of 249 cases. Eur J Gynaecol Oncol 23 (2002) 295-299
18. Tinkler S.D., and Cowie V.J. Uterine sarcomas: A review of the Edinburgh experience from 1974 to 1992. Br J Radiol 66 (1993) 998-1001
19. Brooks S.E., Zhan M., Cote T., et al. Surveillance, epidemiology, and end results analysis of 2677 cases of uterine sarcoma 1989-1999. Gynecol Oncol 93 (2004) 204-208
20. Denschlag D., Masoud I., Stanimir G., et al. Prognostic factors and outcome in women with uterine sarcoma. Eur J Surg Oncol 33 (2007) 91-95
21. Yoney A., Eren B., Eskici S., et al. Retrospective analysis of 105 cases with uterine sarcoma. Bull Cancer 95 (2008) E10-E17
22. Echt G., Jepson J., Steel J., et al. Treatment of uterine sarcomas. Cancer 66 (1990) 35-39
23. Li N., Wu L.Y., Zhang H.T., et al. Treatment options in stage I endometrial stromal sarcoma: A retrospective analysis of 53 cases. Gynecol Oncol 108 (2008) 306-311
24. Hensley M.L., Blessing J.A., Mannel R., et al. Fixed-dose rate gemcitabine plus docetaxel as first-line therapy for metastatic uterine leiomyosarcoma: A Gynecologic Oncology Group phase II trial. Gynecol Oncol 109 (2008) 329-334
25. Omura G.A., Blessing J.A., Major F., et al. A randomized clinical trial of adjuvant adriamycin in uterine sarcomas: A Gynecologic Oncology Group Study. J Clin Oncol 3 (1985) 1240-1245
26. Hornback N.B., Omura G., and Major F.J. Observations on the use of adjuvant radiation therapy in patients with stage I and II uterine sarcoma. Int J Radiat Oncol Biol Phys 12 (1986) 2127-2130
27. Wolfson A.H., Brady M.F., Rocereto T., et al. A gynecologic oncology group randomized phase III trial of whole abdominal irradiation (WAI) vs. cisplatin-ifosfamide and mesna (CIM) as post-surgical therapy in stage I-IV carcinosarcoma (CS) of the uterus. Gynecol Oncol 107 (2007) 177-185
28. Knocke T.H., Weitmann H.D., Kucera H., et al. Results of primary and adjuvant radiotherapy in the treatment of mixed Mullerian tumors of the corpus uteri. Gynecol Oncol 73 (1999) 389-395
29. Sartori E., Bazzurini L., Gadducci A., et al. Carcinosarcoma of the uterus: A clinicopathological multicenter CTF study. Gynecol Oncol 67 (1997) 70-75